United Therapeutics Corp., of Silver Spring, Md., reported its fourth-quarter earnings, showing net income of $9.5 million, or 17 cents per share, falling well below consensus estimates of 62 cents per share. Total revenue also fell below expectations, coming in at $166.5 million vs. consensus estimates of $174.9 million.